Antibody

1,032개 · ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved1,032 programs
AntibodyLimited DatastaleThe First Affiliated Hospital o…Phase 2

Adebrelimab Combined with Bevacizumab and Docetaxel (Adebrelimab Combined with Bevacizumab and Docetaxel)

Non-small Cell Lung Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#Antibody#Phase2#monoclonal-antibody#The
Trials 1Status Active
AntibodyLimited DatastaleNational Cancer Institute (NCI)Phase 1

Adenoviral Transduced Autologous Human Epidermal Growth Factor Receptor (AdHER, Adenoviral Transduced Autologous Human Epidermal Growth Factor Receptor, Adenoviral Transduced Autologous Human Epidermal Growth Factor Receptor (AdHER)2/neu Dendritic Cell (DC) Vaccine)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase1#monoclonal-antibody#BreastNeoplasms+2
Trials 1Status Active
AntibodyLimited DatastaleMedical College of WisconsinPhase 1

atezolizumab (Tecentriq, Adjuvant Atezolizumab)

Head and Neck Neoplasm · Head and Neck Neoplasm

#HeadandNeckNeoplasm#Antibody#Phase1#monoclonal-antibody#Medical
Trials 1Status Active
AntibodyLimited DatastaleThe Netherlands Cancer InstitutePhase 3

nivolumab (Opdivo, Adjuvant nivolumab)

Malignant Melanoma Stage III · Malignant Melanoma Stage III

#MalignantMelanomaStageIII#Antibody#Phase3#monoclonal-antibody#The
Trials 1Status Recruiting
AntibodyLimited DatastaleRochePhase 2

Administration of rituximab and methylprednisolone (Administration of rituximab and methylprednisolone)

Early and Severe Systemic Sclerosis · Early and Severe Systemic Sclerosis

#EarlyandSevereSystemicSclerosis#Antibody#Phase2#monoclonal-antibody#Roche
Trials 1Status Active
AntibodyLimited DatastaleRochePreclinical

trastuzumab (Herceptin, Ado-trastuzumab emtamsine)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Preclinical#monoclonal-antibody#Roche
Trials 1Status Recruiting
AntibodyLimited DatastaleAbbViePhase 3

Adalimumab (Advixa, Advixa (Adalimumab))

Pharmacokinetics; Safety · Pharmacokinetics

#Pharmacokinetics#Antibody#Phase3#monoclonal-antibody#Safety+1
Trials 1Status Active
AntibodyLimited DatastaleChinese Medical AssociationApproved

Akkermansia muciniphila + Infliximab (Akkermansia muciniphila + Infliximab)

Crohn's Diseases · Crohn's Diseases

#CrohnsDiseases#Antibody#Approved#monoclonal-antibody#Chinese
Trials 1Status Recruiting
AntibodyLimited DatastaleGoethe UniversityPhase 2

MabCampath (Alemtuzumab, Alemtuzumab (MabCampath))

Adult Acute Lymphocytic Leukemia T-cell; Lymphoma, Lymphoblastic · Adult Acute Lymphocytic Leukemia T-cell

#AdultAcuteLymphocyticLeukemiaT-c#Antibody#Phase2#monoclonal-antibody#Lymphoma+2
Trials 1Status Active
AntibodyLimited DatastaleGerman CLL Study GroupPhase 2

Alemtuzumab i.v. (Alemtuzumab i.v.)

Chronic Lymphocytic Leukemia · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#Antibody#Phase2#monoclonal-antibody#German
Trials 1Status Active
AntibodyLimited DatastaleGerman CLL Study GroupPhase 2

Alemtuzumab s.c. (Alemtuzumab s.c.)

Chronic Lymphocytic Leukemia · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#Antibody#Phase2#monoclonal-antibody#German
Trials 1Status Active
AntibodyLimited DatastaleKymab LimitedPhase 2

Alomfilimab (Alomfilimab)

Squamous Cell Carcinoma of Head and Neck; Non-small Cell Lung Cancer · Squamous Cell Carcinoma of Head and Neck

#SquamousCellCarcinomaofHeadandNe#Antibody#Phase2#monoclonal-antibody#Non-smallCellLungCancer+1
Trials 1Status Discontinued
AntibodyLimited DatastaleShanghai Celfuture Biotech Co.,…Phase 2

Ametumumab (Ametumumab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#monoclonal-antibody#Shanghai
Trials 1Status Active
AntibodyLimited DatastaleJanssenPhase 2

Amivantamab and Recombinant Human Hyaluronidase (Amivantamab and Recombinant Human Hyaluronidase)

Locally Recurrent Skin Squamous Cell Carcinoma; Metastatic Skin Squamous Cell Carcinoma · Locally Recurrent Skin Squamous Cell Car

#LocallyRecurrentSkinSquamousCell#Antibody#Phase2#monoclonal-antibody#MetastaticSkinSquamousCellCarcin+1
Trials 1Status Discontinued
AntibodyLimited DatastaleAstraZenecaPreclinical

Anifrolumab (Anifrolumab)

Systemic Lupus Erythematosus · Systemic Lupus Erythematosus

#SystemicLupusErythematosus#Antibody#Preclinical#monoclonal-antibody#AstraZeneca
Trials 1Status Recruiting
AntibodyLimited DatastaleShanghai Zhongshan HospitalPhase 2

nivolumab (Opdivo, Anlotinib Hydrochloride With Nivolumab)

Gastric Adenocarcinoma; Esophageal Squamous Cell Carcinoma · Gastric Adenocarcinoma

#GastricAdenocarcinoma#Antibody#Phase2#monoclonal-antibody#EsophagealSquamousCellCarcinoma+1
Trials 1Status Active
AntibodyLimited DatastaleHenan Cancer HospitalPhase 2

durvalumab (Imfinzi, Anlotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung Cancer)

SCLC, Extensive Stage · SCLC, Extensive Stage

#SCLCExtensiveStage#Antibody#Phase2#monoclonal-antibody#SCLC+2
Trials 1Status Active
AntibodyLimited DatastaleGlaxoSmithKlinePhase 2

Tositumomab and Iodine I 131 Tositumomab (Anti-B1 Antibody and Iodine-131 Anti-B1 Antibody, Anti-B1 Antibody and Iodine-131 Anti-B1 Antibody (Tositumomab and Iodine I 131 Tositumomab))

Lymphoma, Non-Hodgkin · Lymphoma, Non-Hodgkin

#LymphomaNon-Hodgkin#Antibody#Phase2#monoclonal-antibody#Lymphoma+2
Trials 1Status Active
AntibodyLimited DatastaleBenaroya Research InstitutePhase 2

Panitumumab or Cetuximab (Anti-EGFR, Anti-EGFR (Panitumumab or Cetuximab))

Colorectal Cancer; Cholangiocarcinoma · EGFR

#EGFR#Antibody#Phase2#monoclonal-antibody#ColorectalCancer+2
Trials 1Status Active
AntibodyLimited DatastaleRochePhase 2

Anti-PD-1 Antibody Plus Chidamide and Rituximab (Anti-PD-1 Antibody Plus Chidamide and Rituximab)

Relapsed or Refractory DLBCL · PD-1

#PD-1#Antibody#Phase2#monoclonal-antibody#RelapsedorRefractoryDLBCL+1
Trials 1Status Active

18 / 52 pages

← PreviousNext →